From Neuroplasticity to Symptom Relief: Converging Mechanisms Driving Durable Therapeutic Benefit

• Examining how neuroplastic changes translate into meaningful clinical improvement across depression and related disorders
• Understanding disease related circuit pathology and how targeted therapeutics can repair dysfunctional synapses and circuits
• Comparing neuroplasticity signatures across ketamine, psychedelics, and emerging agents to identify shared mechanistic pathways
• Bridging the gap between molecular plasticity findings and the encoding of lasting therapeutic effects

Speakers:

Scott Thompson

Professor, Department of Psychiatry

University of Colorado Anschutz Medical Campus